Cargando…
JAK1 truncating mutations in gynecologic cancer define new role of cancer-associated protein tyrosine kinase aberrations
Cancer-associated protein tyrosine kinase (PTK) mutations usually are gain-of-function (GOF) mutations that drive tumor growth and metastasis. We have found 50 JAK1 truncating mutations in 36 of 635 gynecologic tumors in the Total Cancer Care® (TCC®) tumor bank. Among cancer cell lines containing JA...
Autores principales: | Ren, Yuan, Zhang, Yonghong, Liu, Richard Z., Fenstermacher, David A., Wright, Kenneth L., Teer, Jamie K., Wu, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3807107/ https://www.ncbi.nlm.nih.gov/pubmed/24154688 http://dx.doi.org/10.1038/srep03042 |
Ejemplares similares
-
Mechanistic Insights into Regulation of JAK2 Tyrosine Kinase
por: Hubbard, Stevan R.
Publicado: (2018) -
Unlocking Doors without Keys: Activation of Src by Truncated C-terminal Intracellular Receptor Tyrosine Kinases Lacking Tyrosine Kinase Activity
por: Mezquita, Belén, et al.
Publicado: (2014) -
Structural Insights into the Interaction of Heme with Protein Tyrosine Kinase JAK2
por: Schmalohr, Benjamin Franz, et al.
Publicado: (2020) -
Pseudocirrhosis in Chronic Budd Chiari Syndrome With Janus Tyrosine Kinase 2 (JAK2) Mutation
por: Lakshmanan, Seetha, et al.
Publicado: (2020) -
Activating Mutation (V617F) in the Tyrosine Kinase JAK2 is Absent in Locally-Confined or Castration-Resistant Prostate Cancer
por: Gu, Lei, et al.
Publicado: (2010)